Since we observed that HLJ1 expression was negatively correlated with SOCS3 but not with IL-6, LIF, ROS, or EGFR, further analysis of JAK1/2 activation could offer deeper insights into the molecular mechanisms by which HLJ1 regulates peritumoral STAT3 activation and subsequent liver cancer niche formation. This evidence concerns the gene IL6 and liver cancer.